Location History:
- Somerville, MA (US) (1997)
- Fort Lee, NJ (US) (2008 - 2012)
- New York, NY (US) (2018 - 2020)
Company Filing History:
1 out of 81 
1 out of 1 
4 out of 832,843 Years Active: 1997-2020
Title: Paul Diamond: Innovator in Cancer Treatment
Introduction
Paul Diamond is a notable inventor based in Fort Lee, NJ (US), recognized for his contributions to cancer treatment through innovative therapeutic methods. With a total of 7 patents, his work focuses on advancing medical science and improving patient outcomes.
Latest Patents
Among his latest patents, one significant invention is related to sphingosine pathway modulating compounds for the treatment of cancers. This invention provides methods and compositions for treating cancers and myeloproliferative disorders using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod. Another important patent involves combination therapy for the inhibition of metastasis and tumorigenesis. This invention offers therapeutic compositions and methods aimed at inhibiting metastasis and treating cancers in both human and non-human mammals, focusing on the coformulation and/or coadministration of a dehydropyrimidine dehydrogenase inhibitor like gimeracil and a pyrrolopyrimidine compound.
Career Highlights
Throughout his career, Paul Diamond has worked with various organizations, including Enzo Biochem, Inc. His innovative approaches have significantly impacted the field of oncology, showcasing his dedication to improving cancer therapies.
Collaborations
Paul has collaborated with esteemed colleagues such as David A. Dorward and Elazar S. Rabbani, contributing to a rich exchange of ideas and advancements in their shared field of expertise.
Conclusion
Paul Diamond's work exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. His patents and collaborations reflect a commitment to enhancing therapeutic options for patients.